CD8 T cell exhaustion in human visceral leishmaniasis

Journal of Infectious Diseases

Volumn 209, Issue 2, 2014, Pages 290-299

  Gautam, Shalini ^a   Kumar, Rajiv ^a   Singh, Neetu ^a   Singh, Abhishek Kumar ^a   Rai, Madhukar ^a   Sacks, David ^b   Sundar, Shyam ^a   Nylén, Susanne ^c  

^a BANARAS HINDU UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CD8 T cell; CTLA 4; IL 10; PBMC; PD1; Spleen; Visceral leishmaniasis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GRANZYME A; INTERLEUKIN 10; MESSENGER RNA; NEUTRALIZING ANTIBODY; PERFORIN; PROGRAMMED DEATH 1 RECEPTOR;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PARASITE LOAD; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VISCERAL LEISHMANIASIS;

EID: 84891509164     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit401     Document Type: Article

References (35)

1. Kaye PM, Cooke A, Lund T, Wattie M, Blackwell JM. Altered course of visceral leishmaniasis in mice expressing transgenic I-E molecules. Eur J Immunol 1992; 22:357-64
2. Stager S, Smith DF, Kaye PM. Immunization with a recombinant stageregulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J Immunol 2000; 165:7064-71
3. Stern JJ, Oca MJ, Rubin BY, Anderson SL, Murray HW. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. J Immunol 1988; 140:3971-7
4. Tsagozis P, Karagouni E, Dotsika E. CD8(+) T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis. Parasite Immunol 2003; 25:569-79
5. Tsagozis P, Karagouni E, Dotsika E. Function of CD8+ T lymphocytes in a self-curing mouse model of visceral leishmaniasis. Parasitol Int 2005; 54:139-46
6. Nateghi Rostami M, Keshavarz Valian H, Eskandari SE, et al. Differential in vitro CD4+/CD8+ T-cell response to live vs. killed Leishmania major. Parasite Immunol 2010; 32:101-10
7. Santos CD, Boaventura V, Ribeiro Cardoso C, et al. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNgamma(+)-mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol 2013; 133:1533-40
8. Bousoffara T, Louzir H, Ben Salah A, Dellagi K. Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis. J Infect Dis 2004; 189:1265-73
9. Brodskyn CI, Barral A, Boaventura V, Carvalho E, Barral-Netto M. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J Immunol 1997; 159:4467-73
10. Bourreau E, Ronet C, Couppie P, Sainte-Marie D, Tacchini-Cottier F, Launois P. IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis. Microbes Infect 2007; 9:1034-41
11. Saha S, Mondal S, Ravindran R, et al. IL-10-And TGF-beta-mediated susceptibility in kala-Azar and post-kala-Azar dermal leishmaniasis: The significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol 2007; 179:5592-603
12. Abel M, Sene D, Pol S, et al. Intrahepatic virus-specific IL-10-producing CD8T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 2006; 44:1607-16
13. Joshi T, Rodriguez S, Perovic V, Cockburn IA, Stager S. B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections. PLoS Pathog 2009; 5:e1000431
14. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004; 4:336-47
15. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIVspecific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-4
16. Kaufmann DE, Kavanagh DG, Pereyra F, et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007; 8:1246-54
17. Murphy ML, Cotterell SE, Gorak PM, Engwerda CR, Kaye PM. Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J Immunol 1998; 161:4153-60
18. Zubairi S, Sanos SL, Hill S, Kaye PM. Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani. Eur J Immunol 2004; 34:1433-40
19. Clarencio J, de Oliveira CI, Favali C, et al. Could the lower frequency of CD8+CD18+CD45RO+ lymphocytes be biomarkers of human VL? Int Immunol 2009; 21:137-44
20. Katara GK, Ansari NA, Verma S, Ramesh V, Salotra P. Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients. PLoS Negl Trop Dis 2011; 5:e1171
21. Nylen S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, Sacks D. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4 +CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 2007; 204:805-17
22. Ansari NA, Kumar R, Gautam S, et al. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol 2011; 186:3977-85
23. Gautam S, Kumar R, Maurya R, et al. IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis 2011; 204:1134-7
24. Gidwani K, Jones S, Kumar R, Boelaert M, Sundar S. Interferongamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study. PLoS Negl Trop Dis 2011; 5:e1042
25. Smith C, Beagley L, Khanna R. Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression. J Virol 2009; 83:6192-8
26. Gomes NA, Barreto-de-Souza V, Wilson ME, DosReis GA. Unresponsive CD4+ T lymphocytes from Leishmania chagasi-infected mice increase cytokine production and mediate parasite killing after blockade of B7-1/CTLA-4 molecular pathway. J Infect Dis 1998; 178: 1847-51
27. Mingari MC, Ponte M, Bertone S, et al. HLA class I-specific inhibitory receptors in human T lymphocytes: Interleukin 15-induced expression of CD94/NKG2A in superantigen-or alloantigen-Activated CD8+ T cells. Proc Natl Acad Sci U S A 1998; 95:1172-7
28. Anfossi N, Doisne JM, Peyrat MA, et al. Coordinated expression of Iglike inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells. J Immunol 2004; 173:7223-9
29. Sacks DL, Lal SL, Shrivastava SN, Blackwell J, Neva FA. An analysis of T cell responsiveness in Indian kala-Azar. J Immunol 1987; 138: 908-13
30. Mingari MC, Pietra G, Moretta L. Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors. Curr Opin Immunol 2005; 17:312-9
31. Costa P, Rusconi S, Fogli M, et al. Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-Term non-progressor HIV-1-infected patients. AIDS 2003; 17:257-60
32. Costa P, Rusconi S, Mavilio D, et al. Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. AIDS 2001; 15:965-74
33. Nylen S, Maasho K, Soderstrom K, Ilg T, Akuffo H. Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma. Clin Exp Immunol 2003; 131: 457-67
34. Nakamoto N, Cho H, Shaked A, et al. Synergistic reversal of intrahepatic HCV-specific CD8T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 2009; 5:e1000313
35. Polley R, Sanos SL, Prickett S, Haque A, Kaye PM. Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity. Infect Immun 2005; 73:7996-8001